NCT02244814

Brief Summary

The rapidly rising risk of gestational diabetes pregnant women demands that an effective diet strategy be developed due to the high risk of fetal overgrowth, which places the newborn at increased risk for childhood obesity and metabolic syndrome. The aims of this randomized clinical trial are to compare the effects of an 8-wk isocaloric higher complex carbohydrate/lower fat diet vs. a conventional lower carbohydrate (higher fat) diet on glycemic and lipid profiles, maternal insulin resistance, placenta nutrient transporters, the maternal microbiome, neonatal intrahepatic fat, and neonatal total adiposity (primary outcome). The investigators will then follow the infants for 1-yr and measure maternal breast milk and infant microbiome composition to observe if they impact net fat mass gain differently in infants exposed to one diet vs. the other. Identifying a diet for gestational diabetes mellitus women that can effectively alter maternal/fetal metabolism is critical to reducing short- and long-term metabolic risk in this growing cohort of mothers and infants and has the potential to be applicable to overweight/obese pregnant women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 15, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 19, 2014

Completed
10 months until next milestone

Study Start

First participant enrolled

July 1, 2015

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
Last Updated

December 19, 2020

Status Verified

December 1, 2020

Enrollment Period

4.3 years

First QC Date

September 15, 2014

Last Update Submit

December 17, 2020

Conditions

Keywords

glucoseinsulin resistancedietary carbohydratedietary fatadiposityAir displacement plethysmographyDual X-ray Absorptiometrycontinuous glucose monitoring

Outcome Measures

Primary Outcomes (1)

  • Neonatal adiposity

    Air-displacement plethysmography

    5-7 days after birth

Secondary Outcomes (2)

  • Maternal Insulin Resistance

    36 wks gestation

  • Placental fatty acid transporter protein-2 expression

    Delivery

Other Outcomes (3)

  • Oral glucose tolerance test

    Baseline, 36 wks

  • Adipose Tissue Lipolysis

    Baseline, 36 wks

  • Infant Adiposity

    Birth-12 mos

Study Arms (2)

Choosing Healthy Options in Carbohydrate Energy

EXPERIMENTAL

60% carbohydrate/25% fat/15% protein diet

Behavioral: Low Carbohydrate/ConventionalBehavioral: Choosing Healthy Options in Carbohydrate Energy

Low Carbohydrate/Conventional

ACTIVE COMPARATOR

40% carbohydrate/45% fat/15% protein

Behavioral: Low Carbohydrate/ConventionalBehavioral: Choosing Healthy Options in Carbohydrate Energy

Interventions

Lower-carbohydrate/conventional diet (usual care)

Choosing Healthy Options in Carbohydrate EnergyLow Carbohydrate/Conventional

Choosing Healthy Options in Carbohydrate Energy

Choosing Healthy Options in Carbohydrate EnergyLow Carbohydrate/Conventional

Eligibility Criteria

AgeUp to 36 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pregnant women will be between the ages of 20-36 yrs
  • BMI of 26-39 kg/m2 at the time of diagnosis
  • singleton pregnancy
  • no oral hypoglycemic therapy before entering the study
  • diagnosed with Gestational diabetes according to the criteria established by the American College of Obstetricians and Gynecologists, specifically, they will have 2 abnormal values on a 100-g 3 hr glucose tolerance test 205, 206: Fasting\>95 mg/dL but \<105 mg/dL; 1hr\> 180 mg/dL; 2 hr\>155 mg/dL; 3 hr\>140 mg/dL.

You may not qualify if:

  • extreme hypertriglyceridemia
  • overt diabetes
  • suspected preexisting diabetes (A1C≥6.5%, Fasting glucose\>125 mg/dL, or random glucose \>200/mg/dL)
  • women highly likely to fail diet by any of the following criteria will be excluded:1) Fasting glucose \>105 mg/dL, due to the higher likelihood of failing diet and requiring medical treatment 139; 2) Fasting triglyceride \> 400 mg/dL.
  • non-English speaking
  • Smokers (leading cause of low birth weight)
  • Risk factors for placental insufficiency (hypertension, renal disease, thrombophilias, rheumatologic disease, preeclampsia, steroid use, history of pancreatitis, infectious disease, or intrauterine growth restriction)
  • History of pancreatitis
  • History of pre-term labor
  • Taking beta blockers/glucocorticoids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado/Anschutz Medical Campus

Aurora, Colorado, 80045, United States

Location

Related Publications (1)

  • Hernandez TL, Van Pelt RE, Anderson MA, Daniels LJ, West NA, Donahoo WT, Friedman JE, Barbour LA. A higher-complex carbohydrate diet in gestational diabetes mellitus achieves glucose targets and lowers postprandial lipids: a randomized crossover study. Diabetes Care. 2014;37(5):1254-62. doi: 10.2337/dc13-2411. Epub 2014 Mar 4.

    PMID: 24595632BACKGROUND

MeSH Terms

Conditions

Diabetes, GestationalInsulin ResistanceObesity

Interventions

Congresses as Topic

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperinsulinismOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Study Officials

  • Teri L Hernandez, PhD, RN

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2014

First Posted

September 19, 2014

Study Start

July 1, 2015

Primary Completion

November 1, 2019

Study Completion

November 1, 2020

Last Updated

December 19, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations